DDIEM: drug database for inborn errors of metabolism

Orphanet J Rare Dis. 2020 Jun 11;15(1):146. doi: 10.1186/s13023-020-01428-2.

Abstract

Background: Inborn errors of metabolism (IEM) represent a subclass of rare inherited diseases caused by a wide range of defects in metabolic enzymes or their regulation. Of over a thousand characterized IEMs, only about half are understood at the molecular level, and overall the development of treatment and management strategies has proved challenging. An overview of the changing landscape of therapeutic approaches is helpful in assessing strategic patterns in the approach to therapy, but the information is scattered throughout the literature and public data resources.

Results: We gathered data on therapeutic strategies for 300 diseases into the Drug Database for Inborn Errors of Metabolism (DDIEM). Therapeutic approaches, including both successful and ineffective treatments, were manually classified by their mechanisms of action using a new ontology.

Conclusions: We present a manually curated, ontologically formalized knowledgebase of drugs, therapeutic procedures, and mitigated phenotypes. DDIEM is freely available through a web interface and for download at http://ddiem.phenomebrowser.net.

Keywords: Drug effect; Drug repositioning; Inborn errors of metabolism; Ontology; Orphan disease; Therapeutic procedure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Databases, Pharmaceutical*
  • Humans
  • Metabolism, Inborn Errors*
  • Phenotype
  • Rare Diseases / drug therapy